Treat to target: a proposed new paradigm for the management of Crohn's disease.
about
Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectivesImplementation of the simple endoscopic activity score in crohn's diseaseDiagnosis and management of functional symptoms in inflammatory bowel disease in remissionCapsule Endoscopy for Crohn's Disease: Current Status of Diagnosis and ManagementCurrent role of capsule endoscopy in Crohn's diseaseFast-track drug approval in inflammatory bowel diseasesDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesFactors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.Measuring disease activity in Crohn's disease: what is currently available to the clinician.Combination therapy for the treatment of Crohn's disease.Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.Systematic review: Safety of balloon assisted enteroscopy in Crohn's disease.The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in ChinaA guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.An Infectious Pig Model of Crohn's Disease.Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease.Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease.Failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia-Pacific: a need for action.Update on the Medical Management of Crohn's Disease.Use of anti-TNF drug levels to optimise patient management.Relationships of capsule endoscopy Lewis score with clinical disease activity indices, C-reactive protein, and small bowel transit time in pediatric and adult patients with small bowel Crohn's disease.Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.Histologic scoring indices for evaluation of disease activity in Crohn's disease.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target.Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.Dietary Creatine as a Possible Novel Treatment for Crohn's Ileitis.Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.Can We Predict the Efficacy of Anti-TNF-α Agents?Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease.
P2860
Q26740356-AA087319-0395-4272-AF2D-46460B0F88EAQ26749323-1C8071A0-FFFA-41A9-A89E-7634A198AADCQ26768264-8AF78E6B-F7B8-4D04-9C1B-4277F3BC6E66Q26773125-DE22244B-8AB4-4B23-8C5C-24542114A3FAQ28071363-250BE21C-F905-4821-BAD5-E41DECD65284Q28077510-820F518B-4D79-495A-9AAF-B955738E369FQ28085134-279FA85F-A32A-48A2-823D-7360DFB80E8CQ33656852-AD0FE7F5-BA74-4A1D-A51E-4A623A38A080Q33668961-860A2853-63D0-44C2-95E3-8EC758EE49E3Q35714202-AEE4CD4F-FD84-407A-81CA-9A251268301EQ35767936-36CCA24D-05E6-49CB-8FFE-CEF5E9EC8370Q36909512-54E7FD4C-847F-4804-8408-AD7B7957C926Q37231860-73A684C4-4C4D-437E-9090-A9EB495B7A1FQ37373302-9EF7711D-C1EF-4DD4-A89C-B1AA2389EF49Q37427620-DBE3E837-B012-4F67-9B6B-196E1908681AQ37678199-5BE58A92-3275-4138-BDDF-04CCEA40B755Q37835824-5CF0ECA4-A16B-4BE2-AB7E-DB8CD2659D23Q38205873-2D4DB376-C162-4D5B-BFC1-70D6A6C4899AQ38218878-DBDC9B2F-66FA-4139-A4C2-B5D8D7707D13Q38296154-CBA47FAA-7FF0-4A29-8592-D6AB4713D776Q38585634-BF0E9E5C-8792-4C9E-827F-34EBA7B3A416Q38608951-6B588E93-7820-4C46-99B8-EDF9E73242A8Q38620306-A4194F97-29C0-4930-A0B3-4019C423ED8AQ38630959-DA5A1160-0A8E-402F-BF45-C5040C391E2AQ38668188-71E1CF67-D1C3-4B6D-84FB-D66A2BE7CAC5Q38694153-C162F5DE-F49D-4E1E-BBF4-45BFC93033E9Q38766739-3301F991-2A57-4615-BFB1-C94E782F679AQ38798678-74230AB8-8532-4828-92F9-C0DC7E15E934Q38895063-A2F399D9-5367-4897-BC13-4F0ACEA18494Q38895960-2452A95E-44BC-4C36-B0C4-A18FFAE4FBD0Q39046622-8BEAD8BA-D3A4-41C1-8C63-CC3B5647CA3DQ39120033-620D6B1E-A661-4FDE-8834-85E61EC5951FQ39500421-23439A02-16CE-42B9-B499-DE16C8A550B5Q39776906-6825E97C-9D07-4B70-83F1-A108B1728310Q40038096-7997C86C-BD41-4C91-91FC-6DFD5C89A8DCQ40453690-7A35BFBB-C780-424B-9D53-3C514FB93162Q41329796-F5C8786A-6DF2-4904-B6C4-EA2CAECF5BB0Q41660559-CE5CD945-6F8D-4773-A5A5-1543E9E41CC6Q47156789-E14B8C61-94ED-4663-926B-0D4456CE968AQ47598080-71197A24-121F-43F9-A629-761012E200CA
P2860
Treat to target: a proposed new paradigm for the management of Crohn's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treat to target: a proposed new paradigm for the management of Crohn's disease.
@en
type
label
Treat to target: a proposed new paradigm for the management of Crohn's disease.
@en
prefLabel
Treat to target: a proposed new paradigm for the management of Crohn's disease.
@en
P2093
P50
P1476
Treat to target: a proposed new paradigm for the management of Crohn's disease.
@en
P2093
Arthur Kavanaugh
Barrett G Levesque
Guillaume Bouguen
Stephen B Hanauer
P304
1042-50.e2
P356
10.1016/J.CGH.2013.09.006
P407
P577
2013-09-10T00:00:00Z